Lupin partners with Sadoz to commercialise Ranibizumab biosimilar
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Athena is also exploring the use of this technology for expanded carrier screening
cSCC is one of the most common cancers in the U.S. and globally
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
Subscribe To Our Newsletter & Stay Updated